appConfigEntityId

bodyType

customContents

entityId

entityUuid

isVideo

articlePageQuery

article

articleSchemaContent

content

hooksArticlePageAdvertisementConfigArticle

appConfig

filter

json

liveArticle

Confronting cancer in Hong Kong

Is Hong Kong winning the war on cancer or facing new battle in late diagnosis?

How an HKU-developed eczema product could help fight superbug threat

How a Hong Kong app is a ‘vital lifeline’ for 76,000 patients navigating cancer care

Hong Kong healthcare and hospitals

Confronting cancer in Hong Kong. Illustration: Lau Ka-kuen

News

Hong Kong

Health & Environment

Society

Illustration: Mario Cameira

Professor Tony Mok says advances such as targeted therapy and immunotherapy have improved global survival rates. Photo: Jonathan Wong

Professor Yuen Man-fung says he is currently researching drugs that may spare hepatitis B patients from lifelong medication. Photo: Karma Lo

Our Hong Kong Foundation’s Dicky Chow says the city lags in prevention, screening and primary care integration, despite its strengths in treatment and research. Photo: Handout

Hong Kong is seeking to transform itself into a global innovation hub, building on its strengths in cancer research. Photo: Getty Images

While advanced therapies have nearly halved cancer death rate, low screening rates and late detection hold the city back.


‘Silent killer’: the race to beat cancer in Hong Kong

Despite a rising number of cancer cases in Hong Kong, survival rates are improving. Here is what you need to know.


Take2 Health Limited

As cancer is the leading cause of death in Hong Kong, the South China Morning Post’s Health Matters wellness series explores how well the city has tackled the disease while offering residents practical advice on prevention, detection and management.
